Oxidative stress biomarkers and flavonoids in Alzheimer's disease: current clinical evidence and therapeutic perspectives

Redox Report 2026 Open access

Read full text
Authors: Muhammad-Safuan Zainuddin, Narendra Pamidi, Adzzie Shazleen Azman, Kasthuri Bai Magalingam, Saatheeyavaane Bhuvanendran
DOI: 10.1080/13510002.2026.2677396
Cited by: 1
References: 120

Abstract

studies have demonstrated that flavonoids restore antioxidant defences and suppress neuroinflammation, convincing clinical evidence of their efficacy in AD patients remains limited. Overall, these findings emphasize oxidative stress as a therapeutic target requiring further validation efforts.

Fields of Study & Subjects

Alzheimer's disease research and treatments Neurological Disease Mechanisms and Treatments Medicinal Plants and Neuroprotection

Publication details

Journal / source
Redox Report
Publisher
Informa UK Limited
Volume
31
Issue
1
Pages
2677396–2677396
Publication date
26 May 2026
Language
EN